REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Nigra Vaistine (Lithuania)

Main Activities: Pharmacies and Drug Stores | Other Miscellaneous Store Retailers
Secondary Activities: Pharmacies and Drug Stores
Full name: UAB Nigra Vaistine Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Nigra Vaistine is an enterprise based in Lithuania. Its main office is in Silute. The enterprise currently operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on November 04, 1994. 8 (2025) employees currently work for UAB Nigra Vaistine. There was a net sales revenue increase of 11.87% reported in UAB Nigra Vaistine’s latest financial highlights for 2024. The enterprise’s net profit margin decreased by 1.1% in 2024.

Headquarters
M. Jankaus g. 1
Silute; Klaipeda County; Postal Code: LT-99137

Contact Details: Purchase the UAB Nigra Vaistine report to view the information.

Basic Information
Total Employees:
Purchase the UAB Nigra Vaistine report to view the information.
Registered Capital:
Purchase the UAB Nigra Vaistine report to view the information.
Financial Auditors:
Purchase the UAB Nigra Vaistine report to view the information.
Incorporation Date:
November 04, 1994
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Nigra Vaistine report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.87%
Total operating revenue
11.87%
Net Profit (Loss) for the Period
-6.24%
Total Equity
5.06%
Net Profit Margin
-1.1%
Return on Equity (ROE)
-3.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?